NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
March 26, 2017
(Unaudited)
NOTE 1 — BASIS OF PRESENTATION
The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended
June 26, 2016
, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended
June 26, 2016
(the “2016 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is
www.sec.gov
. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at
http://investor.lamresearch.com
. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.
The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end
June 25, 2017
and includes
52
weeks. The quarters ended
March 26, 2017
(the “March 2017 quarter”) and
March 27, 2016
(the “March 2016 quarter”) included
13
weeks.
NOTE 2 — RECENT ACCOUNTING PRONOUNCEMENTS
In May 2014, the FASB released Accounting Standards Update (“ASU”) 2014-9, “Revenue from Contracts with Customers,” to supersede nearly all existing revenue recognition guidance under GAAP. The core principle of the standard is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. The new standard defines a five step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing GAAP, including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation.
In April 2016, the FASB released ASU 2016-10, “Revenue from Contracts with Customers.” The amendment clarifies guidance in ASU 2014-09, “Revenue from Contracts with Customers” to improve guidance on criteria in assessing whether promises to transfer goods and services are separately identifiable and improve the understanding of the licensing implementation guidance.
In May 2016, the FASB released ASU 2016-12, “Revenue from Contracts with Customers,” which also clarifies guidance in ASU 2014-09 on assessing collectability, non-cash consideration, presentation of sales tax and completed contracts and contract modification in transition.
In December 2016, the FASB released ASU 2016-20, “Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers,” which provides for correction or improvement to the guidance previously issued in ASU 2014-09.
The Company is required to adopt these standards starting in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within the standard; or (ii) retrospective with the cumulative effect of initially applying the standard recognized at the date of initial application and providing certain additional disclosures as defined per the standard. The Company has not yet selected a transition method, and is in the process of determining the impact that the new standard will have to its Condensed Consolidated Financial Statements and disclosures thereto. The Company does not plan to early adopt this standard.
In April 2015, the FASB released ASU 2015-3, “Interest – Imputation of Interest.” The amendment requires that debt issuance costs related to recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The Company adopted this standard in the September 2016 quarter, with retrospective application to the June 26, 2016 Condensed Consolidated Balance Sheet. The adoption did not have a material impact to the Condensed Consolidated Financial Statements.
In September 2015, the FASB released ASU 2015-16, “Business Combinations - Simplifying the Accounting for Measurement-Period Adjustments,” which eliminates the requirement to restate prior period financial statements for measurement period adjustments. Instead, the cumulative impact of measurement period adjustments, including the impact to prior periods, is required to be recognized in the reporting period in which the adjustment is identified. The Company adopted this standard in the September 2016 quarter, with no impact to the Condensed Consolidated Financial Statements.
In November 2015, the FASB issued ASU 2015-17, “Balance Sheet Classification of Deferred Taxes.” This ASU amends existing guidance to require that deferred income tax assets and liabilities be classified as non-current in a classified balance sheet, and eliminates the prior guidance which required an entity to separate deferred tax assets and liabilities into a current amount and a non-current amount in a classified balance sheet. The amendments in this ASU are effective for the Company beginning in its first quarter of fiscal year 2018. Earlier application is permitted as of the beginning of an interim or annual period. Additionally, the new guidance may be applied either prospectively to all deferred tax assets and liabilities or retrospectively to all periods presented. The Company plans to adopt the guidance prospectively in its first quarter of fiscal year 2018 with an anticipated reclassification from current assets and liabilities to non-current assets and liabilities on its Condensed Consolidated Balance Sheet.
In January 2016, the FASB released ASU 2016-1, “Financial Instruments - Overall - Recognition and Measurement of Financial Assets and Financial Liabilities.” The amendment changes the accounting for and financial statement presentation of equity investments, other than those accounted for under the equity method of accounting or those that result in consolidation of the investee. The amendment provides clarity on the measurement methodology to be used for the required disclosure of fair value of financial instruments measured at amortized cost on the balance sheet and clarifies that an entity should evaluate the need for a valuation allowance on deferred tax assets related to available-for-sale securities in combination with the entity's other deferred tax assets, among other changes. The Company is required to adopt this standard starting in the first quarter of fiscal year 2019 and does not anticipate that implementation will have a material impact to its Condensed Consolidated Financial Statements.
In January 2016, the FASB released ASU 2016-2, “Leases.” The amendment requires an entity to recognize right-of-use assets and lease liabilities on its balance sheet and disclose key information about leasing arrangements. The amendment offers specific accounting guidance for a lessee, a lessor and sale and leaseback transactions. Lessees and lessors are required to disclose qualitative and quantitative information about leasing arrangements to enable a user of the financial statements to assess the amount, timing and uncertainty of cash flows arising from leases. The Company is required to adopt this standard starting in the first quarter of fiscal year 2020. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.
In March 2016, the FASB released ASU 2016-9, “Compensation - Stock Compensation.” Key changes in the amendment include:
|
|
•
|
entities will be required to recognize all excess tax benefits or deficiencies as an income tax benefit or expense in the income statement, eliminating APIC pools;
|
|
|
•
|
entities will no longer be required to delay recognition of excess tax benefits until they are realized;
|
|
|
•
|
entities will be required to classify the excess tax benefits as an operating activity in the statement of cash flows;
|
|
|
•
|
entities will be allowed to elect an accounting policy to either estimate the number of forfeitures, or account for forfeitures as they occur; and
|
|
|
•
|
entities can withhold up to the maximum individual statutory tax rate without classifying the awards as a liability, the cash paid to satisfy the statutory income tax withholding obligations shall be classified as a financing activity in the statement of cash flows.
|
The Company is required to adopt this standard starting in the first quarter of fiscal year 2018. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.
In June 2016, the FASB released ASU 2016-13, “Financial Instruments - Credit Losses.” The amendment revises the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in more timely recognition of losses on financial instruments, including, but not limited to, available for sale debt securities and accounts receivable. The Company is required to adopt this standard starting in the first quarter of fiscal year 2021. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.
In August 2016, the FASB released ASU 2016-15, “Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments.” The amendment provides and clarifies guidance on the classification of certain cash receipts and cash payments in the statement of cash flows to eliminate diversity in practice. The Company is required to adopt the standard update in the first quarter of fiscal year 2020, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.
In October 2016, the FASB released ASU 2016-16, “Income Tax - Intra-Entity Transfers of Assets Other Than Inventory.” This standard update improves the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. Early adoption is permitted. The Company is required to adopt the standard in the first quarter of fiscal year 2019. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.
In November 2016, the FASB released ASU 2016-18, “Statement of Cash Flows - Restricted Cash.” This standard update requires that restricted cash and restricted cash equivalents be included in cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown in the statement of cash flows. The Company is required to adopt this standard in the first quarter of fiscal year 2019, with a retrospective transition method required. Early adoption is permitted. The Company is currently in the process of evaluating the impact of adoption on its Condensed Consolidated Financial Statements.
NOTE 3 — EQUITY-BASED COMPENSATION PLANS
The Company has stock plans that provide for grants of equity-based awards to eligible participants, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“Market-based PRSUs”) of Lam Research common stock (“Common Stock”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s Market-based PRSUs contain both a market condition and a service condition. The Company’s options, RSU and Market-based PRSU awards typically vest over a period of
three years
. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.
The Company recognized the following equity-based compensation expense and related income tax benefit in the Condensed Consolidated Statements of Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
|
(in thousands)
|
Equity-based compensation expense
|
$
|
35,323
|
|
|
$
|
34,716
|
|
|
$
|
106,173
|
|
|
$
|
103,060
|
|
Income tax benefit recognized related to equity-based compensation expense
|
$
|
9,954
|
|
|
$
|
9,840
|
|
|
$
|
29,674
|
|
|
$
|
28,589
|
|
The estimated fair value of the Company’s stock-based awards, less expected forfeitures, is amortized over the awards’ vesting term on a straight-line basis.
Options and RSUs
The Lam Research Corporation 2015 Stock Incentive Plan, as amended (the “2015 Plan”), provides for the grant of non-qualified equity-based awards to eligible employees and non-employee directors of the Company and its subsidiaries. As of March 26, 2017, outstanding option and RSU awards were granted under the 2015 Plan, the Lam Research Corporation 2007 Stock Incentive Plan, as amended, or the 2011 Stock Incentive Plan, as amended (collectively the “Stock Plans”). A summary of stock plan transactions is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options Outstanding
|
|
RSUs Outstanding
|
|
Number of
Shares
|
|
Weighted-
Average
Exercise Price
|
|
Number of
Shares
|
|
Weighted-
Average
Fair Market
Value
at Grant
|
June 26, 2016
|
907,411
|
|
|
$
|
47.41
|
|
|
4,335,104
|
|
|
$
|
69.30
|
|
Granted
|
90,128
|
|
|
$
|
119.67
|
|
|
1,591,129
|
|
|
$
|
112.67
|
|
Exercised
|
(375,274
|
)
|
|
$
|
34.22
|
|
|
N/A
|
|
|
N/A
|
|
Canceled
|
(13,950
|
)
|
|
$
|
70.02
|
|
|
(128,570
|
)
|
|
$
|
69.24
|
|
Vested restricted stock
|
N/A
|
|
|
N/A
|
|
|
(2,075,045
|
)
|
|
$
|
62.42
|
|
March 26, 2017
|
608,315
|
|
|
$
|
65.73
|
|
|
3,722,618
|
|
|
$
|
88.16
|
|
As of
March 26, 2017
, there was
$5.3 million
of total unrecognized compensation cost related to unvested options granted and outstanding; that cost is expected to be recognized over a weighted-average remaining vesting period of
2.4 years
. As of
March 26, 2017
, there was
$278.6 million
of total unrecognized compensation expense related to unvested RSUs granted; that expense is expected to be recognized over a weighted-average remaining period of
2.4 years
.
ESPP
The 1999 Employee Stock Purchase Plan, as amended and restated (the “1999 ESPP”), allows employees to designate a portion of their base compensation to be withheld through payroll deductions and used to purchase Common Stock at a purchase price per share equal to the lower of
85%
of the fair market value of Common Stock on the first or last day of the applicable purchase period. Each offering period generally lasts up to
14 months
and includes up to
three
interim purchase dates.
Purchase rights under the 1999 ESPP were valued using the Black-Scholes option valuation model and the following weighted-average assumptions for the nine months ended
March 26, 2017
and
March 27, 2016
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
Expected term (years)
|
0.78
|
|
|
0.68
|
|
|
0.73
|
|
|
0.68
|
|
Expected stock price volatility
|
27.24
|
%
|
|
35.61
|
%
|
|
31.80
|
%
|
|
31.85
|
%
|
Risk-free interest rate
|
0.52
|
%
|
|
0.29
|
%
|
|
0.41
|
%
|
|
0.19
|
%
|
Dividend Yield
|
1.00
|
%
|
|
1.18
|
%
|
|
1.10
|
%
|
|
0.95
|
%
|
As of
March 26, 2017
, there was
$10.8 million
of unrecognized compensation expense related to the 1999 ESPP, which is expected to be recognized over a remaining period of approximately
0.6 years
.
NOTE 4 — OTHER EXPENSE, NET
The significant components of other expense, net, are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
|
(in thousands)
|
Interest income
|
$
|
16,345
|
|
|
$
|
8,148
|
|
|
$
|
40,053
|
|
|
$
|
20,637
|
|
Interest expense
|
(24,752
|
)
|
|
(38,056
|
)
|
|
(92,822
|
)
|
|
(101,294
|
)
|
Gains (losses) on deferred compensation plan related assets, net
|
4,294
|
|
|
(999
|
)
|
|
12,131
|
|
|
(4,180
|
)
|
Loss on extinguishment of debt
|
—
|
|
|
—
|
|
|
(36,325
|
)
|
|
—
|
|
Foreign exchange gains, net
|
679
|
|
|
2,457
|
|
|
2,910
|
|
|
2,271
|
|
Other, net
|
(4,404
|
)
|
|
(1,384
|
)
|
|
(11,962
|
)
|
|
(4,324
|
)
|
|
$
|
(7,838
|
)
|
|
$
|
(29,834
|
)
|
|
$
|
(86,015
|
)
|
|
$
|
(86,890
|
)
|
Interest income in the three and nine months ended
March 26, 2017
increased, as compared to the three and nine months ended
March 27, 2016
, due to higher cash and investment balances and higher yield. Interest expense decreased in the March 2017 quarter, as compared to the March 2016 quarter, due to the termination of the October 2015 bridge financing arrangement. Interest expense increased in the nine months ended March 26, 2017 as compared to the nine months ended March 27, 2016, primarily due to interest cost and fees associated with the
$2.4 billion
Senior Note issuance in the three months ended
June 26, 2016
. Loss on extinguishment of debt realized in the nine months ended
March 26, 2017
is a result of the mandatory redemption of the Senior notes due 2023 and 2026, as well as the termination of the Term Loan Agreement (refer to Note 11 and Note 15 for additional details regarding our debt redemptions and termination). The increase in Other, net in the three and nine months ended March 26, 2017, as compared to the three and nine months ended March 27, 2016, is primarily due to increased charitable contributions.
NOTE 5 — INCOME TAX (BENEFIT) EXPENSE
The Company recorded an income tax (benefit) expense of
$(44.1) million
and
$36.8 million
for the
three and nine
months ended
March 26, 2017
, which yielded an effective tax rate of approximately
(8.3)%
and
3.0%
, respectively.
The difference between the U.S. federal statutory tax rate of
35%
and the Company’s effective tax rate for the three months and nine months ended
March 26, 2017
is primarily due to income in lower tax jurisdictions and recognition of previously unrecognized tax benefits from lapse of statutes of limitation related to a prior business combination.
NOTE 6 — NET INCOME PER SHARE
Basic net income per share is computed by dividing net income by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, RSUs, convertible notes, and warrants. Dilutive shares outstanding include the effect of the convertible notes. Refer to Note 11 for additional information regarding the Company's convertible notes. The following table reconciles the numerators and denominators of the basic and diluted computations for net income per share.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
|
(in thousands, except per share data)
|
Numerator:
|
|
|
|
|
|
|
|
Net income
|
$
|
574,713
|
|
|
$
|
143,451
|
|
|
$
|
1,171,339
|
|
|
$
|
655,110
|
|
Denominator:
|
|
|
|
|
|
|
|
Basic average shares outstanding
|
163,408
|
|
|
159,039
|
|
|
162,225
|
|
|
158,605
|
|
Effect of potential dilutive securities:
|
|
|
|
|
|
|
|
Employee stock plans
|
2,107
|
|
|
2,046
|
|
|
2,164
|
|
|
2,208
|
|
Convertible notes
|
16,829
|
|
|
12,999
|
|
|
16,230
|
|
|
13,161
|
|
Warrants
|
2,750
|
|
|
289
|
|
|
2,266
|
|
|
355
|
|
Diluted average shares outstanding
|
185,094
|
|
|
174,373
|
|
|
182,885
|
|
|
174,329
|
|
Net income per share - basic
|
$
|
3.52
|
|
|
$
|
0.90
|
|
|
$
|
7.22
|
|
|
$
|
4.13
|
|
Net income per share - diluted
|
$
|
3.10
|
|
|
$
|
0.82
|
|
|
$
|
6.40
|
|
|
$
|
3.76
|
|
For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The following potentially dilutive securities were excluded:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
|
(in thousands)
|
Number of options and RSUs excluded
|
28
|
|
|
332
|
|
|
135
|
|
|
287
|
|
Diluted shares outstanding do not include any effect resulting from the note hedges associated with the Company’s 2018 Notes as their impact would have been anti-dilutive.
NOTE 7 — FINANCIAL INSTRUMENTS
The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense) in the Condensed Consolidated Statements of Operations. All of the Company’s other investments are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses reported as a separate component of accumulated other comprehensive income (loss), net of tax.
Fair Value
The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.
A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:
Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.
Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data, for substantially the full term of the assets or liabilities.
Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.
The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivative instruments. The estimated fair value of cash, accounts receivable and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. Refer to Note 11 for additional information regarding the fair value of the Company’s Senior Notes and Convertible Notes.
The following table sets forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of
March 26, 2017
and
June 26, 2016
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 26, 2017
|
|
|
|
|
|
|
|
|
(Reported Within)
|
Cost
|
|
Unrealized
Gain
|
|
Unrealized
(Loss)
|
|
Fair Value
|
|
Cash and
Cash
Equivalents
|
|
Investments
|
|
Restricted
Cash &
Investments
|
|
Other
Assets
|
(in thousands)
|
Cash
|
$
|
404,520
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
404,520
|
|
|
$
|
398,391
|
|
|
$
|
—
|
|
|
$
|
6,129
|
|
|
$
|
—
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposit
|
641,357
|
|
|
—
|
|
|
—
|
|
|
641,357
|
|
|
391,329
|
|
|
—
|
|
|
250,028
|
|
|
—
|
|
Money Market Funds
|
1,238,627
|
|
|
—
|
|
|
—
|
|
|
1,238,627
|
|
|
1,238,627
|
|
|
—
|
|
|
—
|
|
|
—
|
|
U.S. Treasury and Agencies
|
732,369
|
|
|
172
|
|
|
(3,245
|
)
|
|
729,296
|
|
|
34,973
|
|
|
694,323
|
|
|
—
|
|
|
—
|
|
Mutual Funds
|
50,374
|
|
|
2,479
|
|
|
—
|
|
|
52,853
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
52,853
|
|
Level 1 Total
|
2,662,727
|
|
|
2,651
|
|
|
(3,245
|
)
|
|
2,662,133
|
|
|
1,664,929
|
|
|
694,323
|
|
|
250,028
|
|
|
52,853
|
|
Level 2:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Municipal Notes and Bonds
|
256,720
|
|
|
168
|
|
|
(76
|
)
|
|
256,812
|
|
|
—
|
|
|
256,812
|
|
|
—
|
|
|
—
|
|
Government-Sponsored Enterprises
|
103,246
|
|
|
5
|
|
|
(35
|
)
|
|
103,216
|
|
|
39,493
|
|
|
63,723
|
|
|
—
|
|
|
—
|
|
Foreign Government Bonds
|
64,141
|
|
|
64
|
|
|
(186
|
)
|
|
64,019
|
|
|
1,287
|
|
|
62,732
|
|
|
—
|
|
|
—
|
|
Corporate Notes and Bonds
|
2,546,895
|
|
|
1,427
|
|
|
(4,170
|
)
|
|
2,544,152
|
|
|
24,470
|
|
|
2,519,682
|
|
|
—
|
|
|
—
|
|
Mortgage Backed Securities — Residential
|
103,560
|
|
|
48
|
|
|
(754
|
)
|
|
102,854
|
|
|
—
|
|
|
102,854
|
|
|
—
|
|
|
—
|
|
Mortgage Backed Securities — Commercial
|
55,214
|
|
|
1
|
|
|
(305
|
)
|
|
54,910
|
|
|
—
|
|
|
54,910
|
|
|
—
|
|
|
—
|
|
Level 2 Total
|
3,129,776
|
|
|
1,713
|
|
|
(5,526
|
)
|
|
3,125,963
|
|
|
65,250
|
|
|
3,060,713
|
|
|
—
|
|
|
—
|
|
Total
|
$
|
6,197,023
|
|
|
$
|
4,364
|
|
|
$
|
(8,771
|
)
|
|
$
|
6,192,616
|
|
|
$
|
2,128,570
|
|
|
$
|
3,755,036
|
|
|
$
|
256,157
|
|
|
$
|
52,853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 26, 2016
|
|
|
|
|
|
|
|
|
(Reported Within)
|
Cost
|
|
Unrealized
Gain
|
|
Unrealized
(Loss)
|
|
Fair Value
|
|
Cash and
Cash
Equivalents
|
|
Investments
|
|
Restricted
Cash &
Investments
|
|
Other
Assets
|
(in thousands)
|
Cash
|
$
|
418,216
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
418,216
|
|
|
$
|
412,573
|
|
|
$
|
—
|
|
|
$
|
5,643
|
|
|
$
|
—
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Time Deposit
|
904,243
|
|
|
—
|
|
|
—
|
|
|
904,243
|
|
|
659,465
|
|
|
—
|
|
|
244,778
|
|
|
—
|
|
Money Market Funds
|
3,904,288
|
|
|
—
|
|
|
—
|
|
|
3,904,288
|
|
|
3,904,288
|
|
|
—
|
|
|
—
|
|
|
—
|
|
U.S. Treasury and Agencies
|
446,530
|
|
|
2,041
|
|
|
(2
|
)
|
|
448,569
|
|
|
62,996
|
|
|
385,573
|
|
|
—
|
|
|
—
|
|
Mutual Funds
|
39,318
|
|
|
1,400
|
|
|
(397
|
)
|
|
40,321
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
40,321
|
|
Level 1 Total
|
5,294,379
|
|
|
3,441
|
|
|
(399
|
)
|
|
5,297,421
|
|
|
4,626,749
|
|
|
385,573
|
|
|
244,778
|
|
|
40,321
|
|
Level 2:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Municipal Notes and Bonds
|
265,386
|
|
|
355
|
|
|
(16
|
)
|
|
265,725
|
|
|
—
|
|
|
265,725
|
|
|
—
|
|
|
—
|
|
U.S. Treasury and Agencies
|
8,068
|
|
|
151
|
|
|
—
|
|
|
8,219
|
|
|
—
|
|
|
8,219
|
|
|
—
|
|
|
—
|
|
Government-Sponsored Enterprises
|
31,885
|
|
|
91
|
|
|
(13
|
)
|
|
31,963
|
|
|
—
|
|
|
31,963
|
|
|
—
|
|
|
—
|
|
Foreign Government Bonds
|
41,440
|
|
|
76
|
|
|
(4
|
)
|
|
41,512
|
|
|
—
|
|
|
41,512
|
|
|
—
|
|
|
—
|
|
Corporate Notes and Bonds
|
979,566
|
|
|
4,341
|
|
|
(566
|
)
|
|
983,341
|
|
|
—
|
|
|
983,341
|
|
|
—
|
|
|
—
|
|
Mortgage Backed Securities — Residential
|
17,395
|
|
|
37
|
|
|
(152
|
)
|
|
17,280
|
|
|
—
|
|
|
17,280
|
|
|
—
|
|
|
—
|
|
Mortgage Backed Securities — Commercial
|
55,129
|
|
|
30
|
|
|
(160
|
)
|
|
54,999
|
|
|
—
|
|
|
54,999
|
|
|
—
|
|
|
—
|
|
Level 2 Total
|
1,398,869
|
|
|
5,081
|
|
|
(911
|
)
|
|
1,403,039
|
|
|
—
|
|
|
1,403,039
|
|
|
—
|
|
|
—
|
|
Total
|
$
|
7,111,464
|
|
|
$
|
8,522
|
|
|
$
|
(1,310
|
)
|
|
$
|
7,118,676
|
|
|
$
|
5,039,322
|
|
|
$
|
1,788,612
|
|
|
$
|
250,421
|
|
|
$
|
40,321
|
|
The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. The Company did
not
recognize any losses on investments due to other-than-temporary impairments during the
three and nine
months ended
March 26, 2017
or
March 27, 2016
. Additionally, gross realized gains and gross realized (losses) from sales of investments were approximately
$0.3 million
and
$(0.7) million
, respectively, in the three months ended
March 26, 2017
and
$0.2 million
and
$(0.3) million
, respectively, in the three months ended
March 27, 2016
. Gross realized gains and gross realized (losses) from sales of investments were approximately
$3.0 million
and
$(1.3) million
, respectively, in the nine months ended
March 26, 2017
and
$1.0 million
and
$(2.4) million
, respectively, in the nine months ended
March 27, 2016
.
The following is an analysis of the Company’s cash, cash equivalents, investments, and restricted cash and investments in unrealized loss positions:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 26, 2017
|
Unrealized Losses
Less Than 12 Months
|
|
Unrealized Losses
12 Months or Greater
|
|
Total
|
Fair Value
|
|
Gross
Unrealized
Loss
|
|
Fair Value
|
|
Gross
Unrealized
Loss
|
|
Fair Value
|
|
Gross
Unrealized
Loss
|
(in thousands)
|
U.S. Treasury & Agencies
|
$
|
607,008
|
|
|
$
|
(3,245
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
607,008
|
|
|
$
|
(3,245
|
)
|
Municipal Notes and Bonds
|
104,474
|
|
|
(56
|
)
|
|
4,980
|
|
|
(20
|
)
|
|
109,454
|
|
|
(76
|
)
|
Government-Sponsored Enterprises
|
50,979
|
|
|
(26
|
)
|
|
533
|
|
|
(9
|
)
|
|
51,512
|
|
|
(35
|
)
|
Foreign Government Bonds
|
38,084
|
|
|
(186
|
)
|
|
—
|
|
|
—
|
|
|
38,084
|
|
|
(186
|
)
|
Corporate Notes and Bonds
|
1,553,348
|
|
|
(4,122
|
)
|
|
19,413
|
|
|
(48
|
)
|
|
1,572,761
|
|
|
(4,170
|
)
|
Mortgage Backed Securities — Residential
|
88,273
|
|
|
(628
|
)
|
|
9,072
|
|
|
(126
|
)
|
|
97,345
|
|
|
(754
|
)
|
Mortgage Backed Securities — Commercial
|
48,481
|
|
|
(294
|
)
|
|
3,755
|
|
|
(11
|
)
|
|
52,236
|
|
|
(305
|
)
|
|
$
|
2,490,647
|
|
|
$
|
(8,557
|
)
|
|
$
|
37,753
|
|
|
$
|
(214
|
)
|
|
$
|
2,528,400
|
|
|
$
|
(8,771
|
)
|
The amortized cost and fair value of cash equivalents, investments and restricted investments with contractual maturities are as follows as of
March 26, 2017
:
|
|
|
|
|
|
|
|
|
|
Cost
|
|
Estimated
Fair
Value
|
(in thousands)
|
Due in one year or less
|
$
|
2,860,355
|
|
|
$
|
2,860,050
|
|
Due after one year through five years
|
2,742,845
|
|
|
2,736,594
|
|
Due in more than five years
|
138,929
|
|
|
138,599
|
|
|
$
|
5,742,129
|
|
|
$
|
5,735,243
|
|
The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than
one year
from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.
Derivative Instruments and Hedging
The Company carries derivative financial instruments (“Derivatives”) on its Condensed Consolidated Balance Sheets at their fair values. The Company enters into foreign currency forward contracts and foreign currency options with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. In addition, the Company enters into interest rate swap arrangements to manage interest rate risk. The counterparties to these Derivatives are large global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.
Cash Flow Hedges
The Company’s financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations on non-U.S. dollar transactions or cash flows, primarily from Japanese yen-denominated revenues, and euro denominated and Korean won-denominated expenses. The Company’s policy is to mitigate the foreign exchange risk arising from the fluctuations in the value of these non-U.S. dollar denominated transactions or cash flows through a foreign currency cash flow hedging program, using forward contracts and foreign currency options that generally expire within
12 months
and no later than
24 months
. These hedge contracts are designated as cash flow hedges and are carried on the Company’s balance sheet at fair value with the effective portion of the contracts’ gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue/expense in the same period the hedged items are recognized.
In addition, during the year ended June 26, 2016, the Company entered into and settled forward-starting interest rate swap agreements to hedge against the variability of cash flows due to changes in certain benchmark interest rates on fixed rate debt. These instruments are designated as cash flow hedges at inception and are settled in conjunction with the issuance of debt. The effective portion of the contracts’ gain or loss is included in accumulated other comprehensive (loss) and is amortized into income as the hedged item impacts earnings.
At inception and at each quarter end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of the forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue or expense in the current period. The change in time value related to these contracts was not material for all reported periods. Changes in the fair value of foreign exchange options due to changes in time value are included in the assessment of effectiveness. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument’s effectiveness in offsetting the exposure to changes in the hedged item’s fair value or cash flows will be measured. There were no material gains or losses during the three or
nine
months ended
March 26, 2017
and
March 27, 2016
associated with ineffectiveness or forecasted transactions that failed to occur.
To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company recognizes effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value associated with the forward contracts and hedge ineffectiveness recognized, the Company’s results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company’s derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in other comprehensive income would be reclassified to income immediately. As of
March 26, 2017
, the Company had losses of
$6.9 million
accumulated in other comprehensive income, net of tax, related to foreign exchange cash flow hedges which it expects to reclassify from other comprehensive income into earnings over the next
12 months
. Additionally, the Company had a net loss of
$1.9 million
accumulated in other comprehensive income, net of tax, related to interest rate contracts which it expects to reclassify from other comprehensive income into earnings over the next
8.0 years
. As a result of the October 5, 2016 termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporation ("KLA-Tencor") (see Note 15 for additional information), a gain of approximately
$1.1 million
accumulated in other comprehensive income, net of tax, related to interest rate contracts associated with the 2026 Notes (as defined in Note 11) were reclassified into earnings in the three months ended December 25, 2016.
Fair Value Hedges
During the fiscal year ended
June 26, 2016
, the Company entered into a series of interest rate contracts with a total notional value of
$400 million
whereby the Company receives fixed rates and pays variable rates based on certain benchmark interest rates, resulting in a net increase or decrease to interest expense, a component of Other expense, net in our Condensed Consolidated Statement of Operations. These interest rate contracts are designated as fair value hedges and hedge against changes in the fair value of our debt portfolio. The Company concluded that these interest rate contracts meet the criteria necessary to qualify for the short-cut method of hedge accounting, and as such an assumption is made that the change in the fair value of the hedged debt, due to changes in the benchmark rate, exactly offsets the change in the fair value of the interest rate swap. Therefore, the derivative is considered to be effective at achieving offsetting changes in the fair value of the hedged liability, and no ineffectiveness is recognized.
Balance Sheet Hedges
The Company also enters into foreign currency forward contracts to hedge fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily third party accounts receivables, accounts payables and intercompany receivables and payables. These forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, which are also recorded in other income (expense).
As of
March 26, 2017
, the Company had the following outstanding foreign currency contracts that were entered into under its cash flow and balance sheet hedge program:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notional Value
|
Derivatives Designated as
Hedging Instruments:
|
|
Derivatives Not Designated
as Hedging Instruments:
|
(in thousands)
|
Foreign Currency Forward Contracts
|
|
|
|
|
|
|
|
|
Buy Contracts
|
|
Sell Contracts
|
|
Buy Contracts
|
|
Sell Contracts
|
Japanese yen
|
$
|
—
|
|
|
$
|
664,752
|
|
|
$
|
—
|
|
|
$
|
177,817
|
|
Euro
|
91,966
|
|
|
—
|
|
|
32,371
|
|
|
—
|
|
Korean won
|
43,105
|
|
|
—
|
|
|
4,185
|
|
|
—
|
|
Taiwan dollar
|
—
|
|
|
—
|
|
|
11,834
|
|
|
—
|
|
Swiss franc
|
—
|
|
|
—
|
|
|
7,394
|
|
|
—
|
|
Chinese renminbi
|
—
|
|
|
—
|
|
|
5,364
|
|
|
|
Singapore dollar
|
—
|
|
|
—
|
|
|
—
|
|
|
5,004
|
|
|
$
|
135,071
|
|
|
$
|
664,752
|
|
|
$
|
61,148
|
|
|
$
|
182,821
|
|
Foreign Currency Option Contracts
|
|
|
|
|
|
|
|
|
Buy Put
|
|
Sell Put
|
|
Buy Put
(1)
|
|
Sell Put
|
Japanese yen
|
$
|
35,709
|
|
|
$
|
—
|
|
|
$
|
30,698
|
|
|
$
|
30,698
|
|
(1) Contracts were entered into and designated as cash flow hedges under ASC 815, during the fiscal year as part of our cash flow hedge program. The contracts were subsequently de-designated during the three and nine months ended Marcy 26, 2017, changes in fair market value subsequent to de-designation effect current earnings.
The fair value of derivative instruments in the Company’s Condensed Consolidated Balance Sheets as of
March 26, 2017
and
June 26, 2016
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 26, 2017
|
|
June 26, 2016
|
Fair Value of Derivative Instruments (Level 2)
|
|
Fair Value of Derivative Instruments (Level 2)
|
Asset Derivatives
|
|
Liability Derivatives
|
|
Asset Derivatives
|
|
Liability Derivatives
|
Balance Sheet
Location
|
|
Fair Value
|
|
Balance Sheet
Location
|
|
Fair Value
|
|
Balance Sheet
Location
|
|
Fair Value
|
|
Balance Sheet
Location
|
|
Fair Value
|
(in thousands)
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
Foreign exchange forward contracts
|
Prepaid expense
and other assets
|
|
$
|
6,661
|
|
|
Accrued liabilities
|
|
$
|
10,962
|
|
|
Prepaid expense
and other assets
|
|
$
|
249
|
|
|
Accrued liabilities
|
|
$
|
16,585
|
|
Interest rate contracts, short-term
|
Prepaid expense and other assets
|
|
973
|
|
|
Prepaid expense
and other assets
|
|
—
|
|
|
Accrued expenses and other current liabilities
|
|
50
|
|
|
Prepaid expense
and other assets
|
|
159
|
|
Interest rate contracts, long-term
|
Other assets
|
|
—
|
|
|
Other long-term liabilities
|
|
18,114
|
|
|
Other assets
|
|
8,661
|
|
|
Other long-term liabilities
|
|
—
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
Foreign exchange forward contracts
|
Prepaid expense
and other assets
|
|
161
|
|
|
Accrued
liabilities
|
|
162
|
|
|
Prepaid expense
and other assets
|
|
107
|
|
|
Accrued
liabilities
|
|
1,529
|
|
Total Derivatives
|
|
|
$
|
7,795
|
|
|
|
|
$
|
29,238
|
|
|
|
|
$
|
9,067
|
|
|
|
|
$
|
18,273
|
|
Under the master netting agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a single net amount payable by one party to the other. However, the Company has elected to present the derivative assets and derivative liabilities on a gross basis on its balance sheet. As of
March 26, 2017
, the potential effect of rights of off-set associated with the above foreign exchange and interest rate contracts would be an offset to assets and liabilities by
$6.6 million
, resulting in a net derivative asset of
$1.2 million
and net derivative liability of
$22.7 million
. As of
June 26, 2016
, the potential effect of rights of set-off associated with the above foreign exchange contracts would be an offset to both assets and liabilities by
$6.4 million
, resulting in a net derivative asset of
$2.7 million
and a net derivative liability of
$11.9 million
. The Company is not required to pledge, nor is the Company entitled to receive, cash collateral for these derivative transactions.
The effect of derivative instruments designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations, including accumulated other comprehensive income (“AOCI”) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 26, 2017
|
|
Nine Months Ended March 26, 2017
|
Effective Portion
|
|
Ineffective
Portion
and Amount
Excluded from
Effectiveness
|
|
Effective Portion
|
|
Ineffective
Portion
and Amount
Excluded from
Effectiveness
|
|
Location of
Gain (Loss)
Recognized
in or
Reclassified
into Income
|
Gain (Loss)
Recognized
in AOCI
|
|
Gain (Loss)
Reclassified
from AOCI
into Income
|
|
Gain (Loss)
Recognized
in Income
|
|
Gain (Loss)
Recognized
in AOCI
|
|
Gain (Loss)
Reclassified
from AOCI
into Income
|
|
Gain (Loss)
Recognized
in Income
|
Derivatives Designated
as Hedging Instruments
|
|
(in thousands)
|
Foreign Exchange Contracts
|
Revenue
|
$
|
(16,734
|
)
|
|
$
|
5,646
|
|
|
2,367
|
|
|
(1,509
|
)
|
|
(8,379
|
)
|
|
3,780
|
|
Foreign Exchange Contracts
|
Cost of goods sold
|
2,095
|
|
|
(56
|
)
|
|
(227
|
)
|
|
1,544
|
|
|
(63
|
)
|
|
(322
|
)
|
Foreign Exchange Contracts
|
Selling, general, and
administrative
|
898
|
|
|
(57
|
)
|
|
(76
|
)
|
|
526
|
|
|
(212
|
)
|
|
(112
|
)
|
Foreign Exchange Contracts
|
Other expense, net
|
—
|
|
|
—
|
|
|
(16
|
)
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
Interest Rate Contracts
|
Other expense, net
|
—
|
|
|
(30
|
)
|
|
—
|
|
|
—
|
|
|
1,757
|
|
|
—
|
|
|
|
$
|
(13,741
|
)
|
|
$
|
5,503
|
|
|
$
|
2,048
|
|
|
$
|
561
|
|
|
$
|
(6,897
|
)
|
|
$
|
3,333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 27, 2016
|
|
Nine Months Ended March 27, 2016
|
Effective Portion
|
|
Ineffective
Portion
and Amount
Excluded from
Effectiveness
|
|
Effective Portion
|
|
Ineffective
Portion
and Amount
Excluded from
Effectiveness
|
|
Location of
Gain (Loss)
Recognized
in or
Reclassified
into Income
|
Gain (Loss)
Recognized
in AOCI
|
|
Gain (Loss)
Reclassified
from AOCI
into Income
|
|
Gain (Loss)
Recognized
in Income
|
|
Gain (Loss)
Recognized
in AOCI
|
|
Gain (Loss)
Reclassified
from AOCI
into Income
|
|
Gain (Loss)
Recognized
in Income
|
Derivatives Designated
as Hedging Instruments
|
|
(in thousands)
|
Foreign Exchange Contracts
|
Revenue
|
$
|
(8,873
|
)
|
|
$
|
3,721
|
|
|
$
|
337
|
|
|
$
|
(4,686
|
)
|
|
$
|
(2,465
|
)
|
|
$
|
584
|
|
Foreign Exchange Contracts
|
Cost of goods sold
|
1,043
|
|
|
61
|
|
|
(61
|
)
|
|
405
|
|
|
2,618
|
|
|
(97
|
)
|
Foreign Exchange Contracts
|
Selling, general, and
administrative
|
317
|
|
|
(113
|
)
|
|
(28
|
)
|
|
291
|
|
|
256
|
|
|
(47
|
)
|
Interest Rate Contracts
|
Other expense, net
|
8,163
|
|
|
(96
|
)
|
|
67
|
|
|
8,163
|
|
|
(285
|
)
|
|
67
|
|
|
|
$
|
650
|
|
|
$
|
3,573
|
|
|
$
|
315
|
|
|
$
|
4,173
|
|
|
$
|
124
|
|
|
$
|
507
|
|
The effect of derivative instruments not designated as cash flow hedges on the Company’s Condensed Consolidated Statements of Operations was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
Derivatives Not Designated as Hedging Instruments:
|
Location
of (Loss) Gain
Recognized
in Income
|
|
Loss
Recognized
in Income
|
|
Gain
Recognized
in Income
|
|
Gain
Recognized
in Income
|
|
Gain
Recognized
in Income
|
|
|
|
(in thousands)
|
Foreign Exchange Contracts
|
Other
income
|
|
$
|
(3,067
|
)
|
|
$
|
3,451
|
|
|
$
|
893
|
|
|
$
|
11,018
|
|
Concentrations of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.
The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Moody’s Investor Services, or Fitch Ratings. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.
The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions and, to date, no such counterparty has failed to meet its financial obligations to the Company.
Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.
NOTE 8 — INVENTORIES
Inventories are stated at the lower of cost (first-in, first-out method) or market. System shipments to Japanese customers, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:
|
|
|
|
|
|
|
|
|
|
March 26,
2017
|
|
June 26,
2016
|
(in thousands)
|
Raw materials
|
$
|
601,057
|
|
|
$
|
536,844
|
|
Work-in-process
|
188,159
|
|
|
151,406
|
|
Finished goods
|
343,980
|
|
|
283,661
|
|
|
$
|
1,133,196
|
|
|
$
|
971,911
|
|
NOTE 9 — GOODWILL AND INTANGIBLE ASSETS
Goodwill
The balance of goodwill is approximately
$1.4 billion
as of
March 26, 2017
and
June 26, 2016
. As of
March 26, 2017
,
$61.1 million
of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law.
Intangible Assets
The following table provides the Company’s intangible assets as of
March 26, 2017
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
|
|
Accumulated
Amortization
|
|
Net
|
(in thousands)
|
Customer relationships
|
$
|
615,141
|
|
|
$
|
(349,991
|
)
|
|
$
|
265,150
|
|
Existing technology
|
643,145
|
|
|
(465,516
|
)
|
|
177,629
|
|
Patents
|
36,553
|
|
|
(30,604
|
)
|
|
5,949
|
|
Other intangible assets
|
36,515
|
|
|
(35,638
|
)
|
|
877
|
|
Total intangible assets
|
$
|
1,331,354
|
|
|
$
|
(881,749
|
)
|
|
$
|
449,605
|
|
The following table provides the Company’s intangible assets as of
June 26, 2016
:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
|
|
Accumulated
Amortization
|
|
Net
|
(in thousands)
|
Customer relationships
|
$
|
615,272
|
|
|
$
|
(300,711
|
)
|
|
$
|
314,561
|
|
Existing technology
|
643,433
|
|
|
(401,036
|
)
|
|
242,397
|
|
Patents
|
36,053
|
|
|
(28,701
|
)
|
|
7,352
|
|
Other intangible assets
|
36,114
|
|
|
(35,503
|
)
|
|
611
|
|
Total intangible assets
|
$
|
1,330,872
|
|
|
$
|
(765,951
|
)
|
|
$
|
564,921
|
|
The Company recognized
$38.6 million
and
$39.1 million
in intangible asset amortization expense during the three months ended
March 26, 2017
and
March 27, 2016
, respectively. The Company recognized
$115.9 million
and
$117.4 million
in intangible asset amortization expense during the nine months ended
March 26, 2017
and
March 27, 2016
, respectively.
The estimated future amortization expense of intangible assets, excluding those with indefinite lives, as of
March 26, 2017
was as follows:
|
|
|
|
|
Fiscal Year
|
Amount
|
|
(in thousands)
|
2017 (remaining 3 months)
|
$
|
38,654
|
|
2018
|
153,515
|
|
2019
|
115,221
|
|
2020
|
50,447
|
|
2021
|
47,763
|
|
Thereafter
|
44,005
|
|
|
$
|
449,605
|
|
NOTE 10 — ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liabilities consist of the following:
|
|
|
|
|
|
|
|
|
|
March 26,
2017
|
|
June 26,
2016
|
(in thousands)
|
Accrued compensation
|
$
|
361,727
|
|
|
$
|
331,528
|
|
Warranty reserves
|
145,141
|
|
|
100,321
|
|
Income and other taxes payable
|
62,294
|
|
|
86,723
|
|
Dividend payable
|
73,953
|
|
|
48,052
|
|
Other
|
207,647
|
|
|
206,286
|
|
|
$
|
850,762
|
|
|
$
|
772,910
|
|
|
|
|
|
NOTE 11 — LONG-TERM DEBT AND OTHER BORROWINGS
As of
March 26, 2017
and
June 26, 2016
, the Company's outstanding debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 26, 2017
|
|
June 26, 2016
|
|
Amount
(in thousands)
|
|
Effective Interest Rate
|
|
Amount
(in thousands)
|
|
Effective Interest Rate
|
Fixed-rate 1.25% Convertible Notes Due May 15, 2018 ("2018 Notes")
|
$
|
449,768
|
|
(1)
|
5.27
|
%
|
|
$
|
449,954
|
|
(2)
|
5.27
|
%
|
Fixed-rate 2.75% Senior Notes Due March 15, 2020 ("2020 Notes")
|
500,000
|
|
|
2.88
|
%
|
|
500,000
|
|
|
2.88
|
%
|
Fixed-rate 2.80% Senior Notes Due June 15, 2021 ("2021 Notes")
|
800,000
|
|
|
2.95
|
%
|
|
800,000
|
|
|
2.95
|
%
|
Fixed-rate 3.45% Senior Notes Due June 15, 2023 ("2023 Notes")
|
—
|
|
|
—
|
|
|
600,000
|
|
|
3.60
|
%
|
Fixed-rate 3.80% Senior Notes Due March 15, 2025 ("2025 Notes")
|
500,000
|
|
|
3.87
|
%
|
|
500,000
|
|
|
3.87
|
%
|
Fixed-rate 3.90% Senior Notes Due June 15, 2026 ("2026 Notes")
|
—
|
|
|
—
|
|
|
1,000,000
|
|
|
4.01
|
%
|
Fixed-rate 2.625% Convertible Notes Due May 15, 2041 ("2041 Notes")
|
631,090
|
|
(1)
|
4.28
|
%
|
|
699,895
|
|
(2)
|
4.28
|
%
|
Total debt outstanding, at par
|
2,880,858
|
|
|
|
|
4,549,849
|
|
|
|
Unamortized discount
|
(184,315
|
)
|
|
|
|
(232,727
|
)
|
|
|
Fair value adjustment - interest rate contracts
|
(17,141
|
)
|
|
|
|
8,552
|
|
|
|
Unamortized bond issuance costs
|
(3,523
|
)
|
|
|
|
(7,213
|
)
|
(3)
|
|
Total debt outstanding, at carrying value
|
$
|
2,675,879
|
|
|
|
|
$
|
4,318,461
|
|
|
|
Reported as:
|
|
|
|
|
|
|
|
Current portion of long-term debt
|
$
|
904,693
|
|
(4)
|
|
|
$
|
940,537
|
|
(4)
|
|
Long-term debt
|
1,771,186
|
|
|
|
|
3,377,924
|
|
|
|
Total debt outstanding, at carrying value
|
$
|
2,675,879
|
|
|
|
|
$
|
4,318,461
|
|
|
|
____________________________
(1)
As of
March 26, 2017
, these notes were convertible at the option of the bondholder, as a result of the condition described in (4) below. Upon closure of the conversion period, Notes not converted will be reclassified back into noncurrent liabilities and the temporary equity will be reclassified into permanent equity.
(2)
As of
June 26, 2016
, these notes were convertible at the option of the bond holder, as a result of the condition described in (4) below.
(3)
The Company adopted ASU 2015-3, regarding the simplification of the presentation of bond issuance costs, which requires that bond issuance costs related to a recognized liability be presented on the balance sheet as a direct reduction from the carrying amount of that debt liability, consistent with debt discounts. The Company applied the accounting standard update on a retrospective basis by reclassifying the presentation of bond issuance costs totaling
$1.76 million
which was originally included in prepaid assets and other current assets against current portion of convertible notes and capital leases, and
$5.45 million
which was originally included in other assets against senior notes, convertible notes, and capital leases, less current portion on the Condensed Consolidated Balance Sheets for
June 26, 2016
. There is no impact to the Company's Condensed Consolidated Statements of Operation, Stockholders' Equity, or Cash Flows for the fiscal year ended
June 26, 2016
.
(4)
As of the report date the market value of the Company's Common Stock was greater than
130%
of the convertible notes conversion price for
20
or more of the
30
consecutive trading days preceding the quarter-end. As a result, the convertible notes were classified in current liabilities and a portion of the equity component, representing the unamortized discount, was classified in temporary equity on the Company's Consolidated Balance Sheets.
Convertible Senior Notes
In May 2011, the Company issued and sold
$450 million
in aggregate principal amount of
1.25%
Convertible Senior Notes due May
2018
(the “2018 Notes”) at par. The Company pays cash interest at an annual rate of
1.25%
, on the 2018 Notes, on a semi-annual basis on May 15 and November 15 of each year.
In June 2012, with the acquisition of Novellus Systems, Inc. (“Novellus”), the Company assumed
$700 million
in aggregate principal amount of
2.625%
Convertible Senior Notes due May
2041
(the “2041 Notes,” and collectively with the 2018 Notes, the “Convertible Notes”). The Company pays cash interest at an annual rate of
2.625%
, on a semi-annual basis on May 15 and November 15 of each year on the 2041 Notes. The 2041 Notes also have a contingent interest payment provision that may require the Company to pay additional interest, up to
0.60%
per year, based on certain thresholds, beginning with the semi-annual interest payment on May 15, 2021, and upon the occurrence of certain events, as outlined in the indenture governing the 2041 Notes.
The Company separately accounts for the liability and equity components of the Convertible Notes. The initial debt components of the Convertible Notes were valued based on the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without the conversion feature, which equals the effective interest rate on the liability component disclosed in the table below, respectively. The equity component was initially valued equal to the principle value of the notes, less the present value of the future cash flows using the Company’s borrowing rate at the date of the issuance or assumption for similar debt instruments without a conversion feature, which equated to the initial debt discount.
Under certain circumstances, the Convertible Notes may be converted into shares of the Company’s Common Stock. The number of shares each debenture is convertible into is based on conversion rates, disclosed in the table below. Conversions in the three and nine months ended
March 26, 2017
were approximately
$68.8 million
and
$69.0 million
principal value of Convertible Notes, respectively.
Selected additional information regarding the Convertible Notes outstanding as of
March 26, 2017
and
June 26, 2016
, the Convertible Notes consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 26, 2017
|
|
June 26, 2016
|
2018 Notes
|
|
2041 Notes
|
|
2018 Notes
|
|
2041 Notes
|
(in thousands, except years, percentages, conversion rate, and conversion price)
|
Carrying amount of permanent equity component, net of tax
|
$
|
85,380
|
|
|
$
|
155,445
|
|
|
$
|
72,992
|
|
|
$
|
152,397
|
|
Carrying amount of temporary equity component, net of tax
|
$
|
19,501
|
|
|
$
|
155,608
|
|
|
$
|
31,894
|
|
|
$
|
175,658
|
|
Remaining amortization period (years)
|
1.1
|
|
|
24.1
|
|
|
1.9
|
|
|
24.9
|
|
Fair Value of Notes (Level 2)
|
$
|
953,193
|
|
|
$
|
2,374,886
|
|
|
|
|
|
Conversion rate (shares of common stock per $1,000 principal amount of notes)
|
16.5232
|
|
|
29.6528
|
|
|
|
|
|
Conversion price (per share of common stock)
|
$
|
60.52
|
|
|
$
|
33.72
|
|
|
|
|
|
If-converted value in excess of par value
|
$
|
497,538
|
|
|
$
|
1,754,331
|
|
|
|
|
|
Estimated share dilution using average quarterly stock price $116.02 per share
|
3,555
|
|
|
13,274
|
|
|
|
|
|
Convertible Note Hedges and Warrants
Concurrent with the issuance of the 2018 Notes and
$450 million
of notes that matured in May of 2016 (the "2016 Notes"), the Company purchased a convertible note hedge and sold warrants. The warrants settlement is contractually defined as net share settlement. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock. During the nine months ended
March 26, 2017
, warrants associated with the 2016 Notes were exercised resulting in the issuance of approximately
2.0 million
shares of the Company's Common Stock. As of
March 26, 2017
, the warrants associated with the 2018 Notes had not been exercised and remained outstanding.
In conjunction with the convertible note hedge, counterparties agreed to sell to the Company shares of Common Stock equal to the number of shares issuable upon conversion of the 2018 Notes in full. The convertible note hedge transactions will be settled in net shares and will terminate upon the earlier of the maturity date or the first day none of the respective notes remain outstanding due to conversion or otherwise. Settlement of the convertible note hedge in net shares, based on the number of shares issued upon conversion of the 2018 Notes, on the expiration date would result in the Company receiving net shares equivalent to the number of shares issuable by the Company upon conversion of the 2018 Notes. The exercise price is adjusted for certain corporate events, including dividends on the Company’s Common Stock.
The following table presents the details of the warrants and convertible note hedge arrangements as of
March 26, 2017
:
|
|
|
|
|
|
|
|
2018 Notes
|
|
(shares in thousands)
|
Warrants:
|
|
|
Underlying shares
|
|
7,435
|
|
Estimated share dilution using average quarterly stock price $116.02 per share
|
|
2,750
|
|
Exercise price
|
|
$
|
73.09
|
|
Expiration date range
|
|
August 15 - October 23, 2018
|
|
Convertible Note Hedge:
|
|
|
Number of shares available from counterparties
|
|
7,432
|
|
Exercise price
|
|
$
|
60.52
|
|
Senior Notes
On March 12, 2015, the Company completed a public offering of
$500 million
aggregate principal amount of the Company’s Senior Notes due
March, 2020
(the “2020 Notes”) and
$500 million
aggregate principal amount of the Company’s Senior Notes due
March, 2025
(the “2025 Notes” and, together with the 2020 Notes, the “Senior Notes”). The Company pays interest at an annual rate of
2.75%
and
3.80%
, respectively, on the 2020 Notes and 2025 Notes, on a semi-annual basis on March 15 and September 15 of each year. During the year ended
June 26, 2016
, the Company entered into a series of interest rate contracts hedging the fair value of a portion of the 2025 Notes par value, whereby the Company receives a fixed rate and pays a variable rate based on a certain benchmark interest rate. Refer to Note 7 for additional information regarding these interest rate contracts.
The Company may redeem the Senior Notes at a redemption price equal to
100%
of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect of the Senior Notes and accrued and unpaid interest before
February 15, 2020
, for the 2020 Notes and before
December 15, 2024
for the 2025 Notes. The Company may redeem the Senior Notes at par, plus accrued and unpaid interest at any time on or after February 15, 2020 for the 2020 Notes and on or after December 24, 2024 for the 2025 Notes. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the Senior Notes at a price equal to
101%
of the principal amount of the Senior Notes, plus accrued and unpaid interest.
On June 7, 2016, The Company completed a public offering of
$800.0 million
aggregate principal amount of Senior Notes due June 2021 (the "2021 Notes"),
$600.0 million
aggregate principal amount of Senior Notes due June 2023 (the "2023 Notes") and
$1,000.0 million
aggregate principal amount of Senior Notes due June 2026 (the "2026 Notes" together with the 2020, 2021, 2023, and 2025 Notes, the “Senior Notes”). The Company will pay interest at an annual rate of
2.80%
,
3.45%
and
3.90%
, respectively, on the 2021 Notes, 2023 Notes and 2026 Notes, on a semi-annual basis on June 15 and December 15 of each year, beginning December 15, 2016.
As a result of the October 5, 2016 termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor (see Note 15 for additional information), the 2023 Notes and the 2026 Notes were redeemed on October 13, 2016 under the Special Mandatory Redemption terms of the indenture governing these Notes. The Company was required to redeem all of the 2023 Notes and the 2026 Notes then outstanding, at a special mandatory redemption price equal to
101%
of the aggregate principal amount of such notes, plus accrued and unpaid interest of approximately
$21.0 million
from the date of initial issuance. In addition, in conjunction with the Special Mandatory Redemption of the 2023 Notes and the 2026 Notes in the three months ended December 25, 2016, the Company recognized approximately
$2.5 million
of loan issuance costs to other expense, net. The 2021 Notes are not subject to Special Mandatory Redemption.
The Company may redeem the 2021 Notes at a redemption price equal to
100%
of the principal amount of such series (“par”), plus a “make whole” premium as described in the indenture in respect to the 2021 Notes and accrued and unpaid interest before May 15, 2021. The Company may redeem the 2021 Notes at par, plus accrued and unpaid interest at any time on or after May 15, 2021. In addition, upon the occurrence of certain events, as described in the indenture, the Company will be required to make an offer to repurchase the 2021 Notes at a price equal to
101%
of the principal amount of the respective note, plus accrued and unpaid interest.
Selected additional information regarding the Senior Notes outstanding as of
March 26, 2017
is as follows:
|
|
|
|
|
|
|
|
Remaining Amortization period
|
|
Fair Value of Notes (Level 2)
|
|
(years)
|
|
(in thousands)
|
2020 Notes
|
3.0
|
|
$
|
505,820
|
|
2021 Notes
|
4.2
|
|
$
|
802,560
|
|
2025 Notes
|
8.0
|
|
$
|
503,910
|
|
Interest Cost
The following table presents the amount of interest cost recognized relating to both the contractual interest coupon and amortization of the debt discount, issuance costs, and effective portion of interest rate contracts with respect to the Convertible Notes, the Senior Notes, the term loan agreement and the revolving credit facility during the
three and nine
months ended
March 26, 2017
and
March 27, 2016
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
|
|
|
|
(in thousands)
|
Contractual interest coupon
|
$
|
19,443
|
|
|
$
|
14,749
|
|
|
$
|
76,777
|
|
|
$
|
44,269
|
|
Amortization of interest discount
|
5,654
|
|
|
8,979
|
|
|
17,241
|
|
|
27,359
|
|
Amortization of issuance costs
|
482
|
|
|
13,124
|
|
|
1,931
|
|
|
28,224
|
|
Effect of interest rate contracts, net
|
(672
|
)
|
|
96
|
|
|
(4,296
|
)
|
|
285
|
|
Total interest cost recognized
|
$
|
24,907
|
|
|
$
|
36,948
|
|
|
$
|
91,653
|
|
|
$
|
100,137
|
|
Term Loan Agreement
On May 13, 2016, we entered into an Amended and Restated Term Loan Agreement (the “Amended and Restated Term Loan Agreement”), which amends and restates the Term Loan Agreement we entered into on November 10, 2015 with a syndicate of lenders. The Amended and Restated Term Loan Agreement provides for a commitment of
$1,530.0 million
senior unsecured term loan facility composed of two tranches (the "Commitments"); (i) a
$1,005.0 million
tranche of 3-year senior unsecured loans; and (ii) a
$525.0 million
tranche of 5-year senior unsecured loans. The Commitments automatically terminated on October 5, 2016, upon termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporation (see Note 15 for additional detail). In conjunction with the termination of the Commitments the Company released approximately
$3.7 million
of loan issuance costs to loss on extinguishment of debt, a component of other expense, net in the three months ended December 25, 2016.
Revolving Credit Facility
On November 10, 2015, we entered into an Amendment and Restatement Agreement (as amended on April 26, 2016 by Amendment No. 1 to the Amended and Restated Credit Agreement, and as further amended, restated, supplemented or otherwise modified from time to time, the “Amended and Restated Credit Agreement”), which amends and restates the Company's prior unsecured Credit Agreement, dated March 12, 2014 (as amended by Amendment No. 1, dated March 5, 2015). The Amended and Restated Credit Agreement provides for an increase to our revolving unsecured credit facility, from
$300.0 million
to
$750.0 million
with a syndicate of lenders. It includes an expansion option, subject to certain requirements, for us to request an increase in the facility of up to an additional
$250.0 million
, for a potential total commitment of
$1.0 billion
. Proceeds from the credit facility can be used for general corporate purposes. The facility matures on November 10, 2020. Termination of the Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporation has no effect to the Amended and Restated Credit Agreement.
Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (i) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus
0.5%
, or (c) one-month LIBOR plus
1.0%
, plus a spread of
0.0%
to
0.5%
, or (ii) LIBOR multiplied by the statutory rate, plus a spread of
0.9%
to
1.5%
in each case as the applicable spread is determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Principal and any accrued and unpaid interest is due and payable upon maturity. Additionally, the Company will pay the lenders a quarterly commitment fee that varies based on the Company’s credit rating. The Restated Credit Agreement contains affirmative covenants, negative covenants, financial covenants and events of default that are substantially similar to those in the Amended and Restated Term Loan Agreement. As of
March 26, 2017
, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.
NOTE 12 — COMMITMENTS AND CONTINGENCIES
Operating Leases and Related Guarantees
The Company leases certain of its administrative, research and development (“R&D”) and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable operating leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.
The Company has operating leases regarding certain improved properties in Fremont and Livermore, California (the “Operating Leases”). The Company was required to maintain cash collateral in an aggregate of approximately
$250.0 million
in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of
March 26, 2017
.
During the term of the Operating Leases and when the terms of the Operating Leases expire, the property subject to those Operating Leases may be remarketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate guarantee made by the Company under the Operating Leases is generally no more than approximately
$220.4 million
; however, under certain default circumstances, the guarantee with regard to an Operating Lease may be
100%
of the lessor’s aggregate investment in the applicable property, which in no case will exceed
$250.0 million
, in the aggregate.
Other Guarantees
The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into certain insurance contracts that are intended to limit its exposure to such indemnifications. As of
March 26, 2017
, the Company had not recorded any liability in connection with these indemnifications, as it does not believe, based on information available, that it is probable that any amounts will be paid under these guarantees.
Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe, based on information available, that it is probable that any material amounts will be paid under these guarantees.
The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of
March 26, 2017
, the maximum potential amount of future payments that it could be required to make under these arrangements and letters of credit was
$15.3 million
. The Company does not believe, based on historical experience and information currently available, that it is probable that any amounts will be required to be paid.
Warranties
The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.
Changes in the Company’s product warranty reserves were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
March 26,
2017
|
|
March 27,
2016
|
|
March 26,
2017
|
|
March 27,
2016
|
(in thousands)
|
Balance at beginning of period
|
$
|
119,334
|
|
|
$
|
97,335
|
|
|
$
|
100,321
|
|
|
$
|
93,209
|
|
Warranties issued during the period
|
54,434
|
|
|
29,645
|
|
|
130,833
|
|
|
89,131
|
|
Settlements made during the period
|
(32,352
|
)
|
|
(30,021
|
)
|
|
(97,327
|
)
|
|
(85,176
|
)
|
Changes in liability for pre-existing warranties
|
3,725
|
|
|
(738
|
)
|
|
11,314
|
|
|
(943
|
)
|
Balance at end of period
|
$
|
145,141
|
|
|
$
|
96,221
|
|
|
$
|
145,141
|
|
|
$
|
96,221
|
|
Legal proceedings
While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual for litigation or other contingencies related to existing legal proceedings.
NOTE 13 — STOCK REPURCHASE PROGRAM
In November 2016, the Board of Directors authorized the repurchase of up to
$1.0 billion
of Common Stock. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases will be funded using the Company’s on-shore cash and on-shore cash generation. This repurchase program has no termination date and may be suspended or discontinued at any time.
Repurchases under the repurchase program were as follows during the periods indicated:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period
|
Total Number of
Shares
Repurchased
|
|
Total Cost of
Repurchase
|
|
Average Price
Paid Per Share
|
|
Amount
Available Under
Repurchase
Program
|
|
(in thousands, except per share data)
|
Available balance as of June 26, 2016
|
|
|
|
|
|
|
$
|
229,094
|
|
Quarter ended September 25, 2016
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
229,094
|
|
Board authorization, November 2016
|
|
|
|
|
|
|
|
|
|
$
|
1,000,000
|
|
Quarter ended December 25, 2016
|
619
|
|
|
$
|
65,014
|
|
|
$
|
105.01
|
|
|
$
|
934,986
|
|
Quarter ended March 26, 2017
|
1,223
|
|
|
139,760
|
|
|
114.30
|
|
|
795,226
|
|
In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and nine months ended
March 26, 2017
, the Company acquired
604 thousand
shares at a total cost of
$70.5 million
and
740 thousand
shares at a total cost of
$83.4 million
, respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of RSU awards granted under the Company's equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.
On April 19, 2017, the Company entered into
two
separate accelerated share repurchase agreements (collectively, the "ASR") with
two
financial institutions to repurchase a total of
$500 million
of Common Stock. The Company took an initial delivery of
2.57 million
shares, which represented
70%
of the prepayment amount divided by Lam's closing stock price on April 19, 2017. The total number of shares to be ultimately received under the ASR will be based upon the average daily volume weighted average price of our common stock during the repurchase period, less an agreed upon discount. Final settlement of the transactions are expected to be completed no sooner than June 5, 2017 or no later than July 21, 2017. As of April 24 2017, there were
$282.1 million
of authorized funds remaining under our stock repurchase authorization.
NOTE 14 — ACCUMULATED OTHER COMPREHENSIVE LOSS
The components of accumulated other comprehensive income (loss) (“AOCI”), net of tax at the end of the period, as well as the activity during the period, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated foreign
currency
translation
adjustment
|
|
Accumulated
unrealized
holding
gain (loss) on cash flow
hedges
|
|
Accumulated
unrealized
holding
gain (loss) on available-
for-sale investments
|
|
Accumulated
unrealized
components
of defined
benefit plans
|
|
Total
|
(in thousands)
|
Balance as of June 26, 2016
|
$
|
(39,528
|
)
|
|
$
|
(15,623
|
)
|
|
$
|
4,896
|
|
|
$
|
(19,078
|
)
|
|
$
|
(69,333
|
)
|
Other comprehensive income (loss) before reclassifications
|
(3,478
|
)
|
|
326
|
|
|
(10,713
|
)
|
|
369
|
|
|
(13,496
|
)
|
Losses reclassified from accumulated other comprehensive income (loss) to net income
|
199
|
|
(1)
|
6,544
|
|
(2)
|
484
|
|
(1)
|
—
|
|
|
7,227
|
|
Net current-period other comprehensive income (loss)
|
$
|
(3,279
|
)
|
|
$
|
6,870
|
|
|
$
|
(10,229
|
)
|
|
$
|
369
|
|
|
$
|
(6,269
|
)
|
Balance as of March 26, 2017
|
$
|
(42,807
|
)
|
|
$
|
(8,753
|
)
|
|
$
|
(5,333
|
)
|
|
$
|
(18,709
|
)
|
|
$
|
(75,602
|
)
|
|
|
(1)
|
Amount of after tax gain reclassified from accumulated other comprehensive income into net income located in other expense, net.
|
|
|
(2)
|
Amount of after tax gain reclassified from AOCI into net income located in revenue:
$7,449
loss; cost of goods sold:
$30
loss; selling, general and administrative expenses:
$162
loss; and other income and expense:
$1,097
gain.
|
NOTE 15 – BUSINESS COMBINATIONS
On October 20, 2015, the Company entered into an Agreement and Plan of Merger and Reorganization with KLA-Tencor Corporation (“KLA-Tencor”). On October 5, 2016, the Company and KLA-Tencor announced that they had mutually agreed to terminate their previously announced Agreement and Plan of Merger and Reorganization. No termination fee is payable by either the Company or KLA-Tencor.
During the nine months ended
March 26, 2017
the Company expensed acquisition-related costs as incurred of
$9.8 million
, within selling, general, and administrative expense in the Condensed Consolidated Statement of Operations. No acquisition-related costs were incurred in the three months ended
March 26, 2017
.